NXGN
Income statement / Annual
Last year (2023), NextGen Healthcare, Inc.'s total revenue was $653.17 M,
an increase of 9.53% from the previous year.
In 2023, NextGen Healthcare, Inc.'s net income was -$2.65 M.
See NextGen Healthcare, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
03/31/2014 |
| Operating Revenue |
$653.17 M |
$596.35 M |
$556.82 M |
$540.24 M |
$529.17 M |
$531.02 M |
$509.62 M |
$492.48 M |
$490.23 M |
$444.67 M |
| Cost of Revenue |
$342.01 M
|
$295.40 M
|
$275.42 M
|
$267.44 M
|
$246.70 M
|
$241.54 M
|
$223.13 M
|
$225.62 M
|
$223.16 M
|
$220.16 M
|
| Gross Profit |
$311.16 M
|
$300.95 M
|
$281.40 M
|
$272.80 M
|
$282.48 M
|
$289.48 M
|
$286.49 M
|
$266.86 M
|
$267.06 M
|
$224.50 M
|
| Gross Profit Ratio |
0.48
|
0.5
|
0.51
|
0.5
|
0.53
|
0.55
|
0.56
|
0.54
|
0.54
|
0.5
|
| Research and Development Expenses |
$82.30 M
|
$76.66 M
|
$75.50 M
|
$83.30 M
|
$80.99 M
|
$81.26 M
|
$78.34 M
|
$65.66 M
|
$69.24 M
|
$41.52 M
|
| General & Administrative Expenses |
$213.15 M
|
$202.88 M
|
$176.63 M
|
$159.13 M
|
$156.65 M
|
$184.15 M
|
$156.51 M
|
$148.34 M
|
$151.09 M
|
$133.49 M
|
| Selling & Marketing Expenses |
$10.27 M
|
$6.78 M
|
$3.90 M
|
$6.04 M
|
$8.23 M
|
$9.07 M
|
$7.11 M
|
$7.89 M
|
$7.08 M
|
$15.72 M
|
| Selling, General & Administrative Expenses |
$223.42 M
|
$209.66 M
|
$180.53 M
|
$165.17 M
|
$164.88 M
|
$193.23 M
|
$163.62 M
|
$156.23 M
|
$158.17 M
|
$149.21 M
|
| Other Expenses |
$3.67 M
|
$3.53 M
|
$4.45 M
|
$4.14 M
|
$4.34 M
|
$37,000.00
|
-$262,000.00
|
-$166,000.00
|
-$62,000.00
|
-$356,000.00
|
| Operating Expenses |
$309.39 M
|
$289.84 M
|
$260.48 M
|
$252.61 M
|
$250.22 M
|
$282.30 M
|
$252.40 M
|
$227.26 M
|
$231.11 M
|
$195.54 M
|
| Cost And Expenses |
$651.40 M
|
$585.25 M
|
$535.90 M
|
$520.05 M
|
$496.91 M
|
$523.83 M
|
$475.53 M
|
$452.88 M
|
$454.27 M
|
$415.71 M
|
| Interest Income |
$3.54 M
|
$101,000.00
|
$38,000.00
|
$256,000.00
|
$216,000.00
|
$55,000.00
|
$14,000.00
|
$428,000.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.30 M
|
$1.50 M
|
$3.52 M
|
$1.96 M
|
$2.81 M
|
$3.32 M
|
$3.16 M
|
$1.30 M
|
$0.00
|
$269,000.00
|
| Depreciation & Amortization |
$36.69 M
|
$42.32 M
|
$49.21 M
|
$4.14 M
|
$5.47 M
|
$7.81 M
|
$40.43 M
|
$5.37 M
|
$3.69 M
|
$4.81 M
|
| EBITDA |
$48.04 M |
$53.46 M |
$70.11 M |
$25.43 M |
$37.09 M |
$2.82 M |
$58.85 M |
$7.36 M |
$35.96 M |
$23.09 M |
| EBITDA Ratio |
0.08
|
0.09
|
0.13
|
0.05
|
0.07
|
0.03
|
0.15
|
0.09
|
0.08
|
0.09
|
| Operating Income Ratio |
0.02
|
0.02
|
0.04
|
0.04
|
0.06
|
0.01
|
0.05
|
0.01
|
0.07
|
0.05
|
| Total Other Income/Expenses Net |
$8.17 M
|
-$5.94 M
|
-$10.28 M
|
-$14.98 M
|
-$2.33 M
|
-$3.23 M
|
-$3.40 M
|
-$1.04 M
|
-$292,000.00
|
-$87,000.00
|
| Income Before Tax |
$4.30 M
|
$5.20 M
|
$9.28 M
|
$4.26 M
|
$29.29 M
|
-$410,000.00
|
$23.61 M
|
$6.32 M
|
$35.66 M
|
$23.00 M
|
| Income Before Tax Ratio |
0.01
|
0.01
|
0.02
|
0.01
|
0.06
|
-0
|
0.05
|
0.01
|
0.07
|
0.05
|
| Income Tax Expense |
$6.96 M
|
$3.58 M
|
-$240,000.00
|
-$3.24 M
|
$4.79 M
|
-$2.83 M
|
$5.37 M
|
$663,000.00
|
$8.33 M
|
$7.32 M
|
| Net Income |
-$2.65 M
|
$1.62 M
|
$9.52 M
|
$7.50 M
|
$24.49 M
|
$2.42 M
|
$18.24 M
|
$5.66 M
|
$27.33 M
|
$15.68 M
|
| Net Income Ratio |
-0
|
0
|
0.02
|
0.01
|
0.05
|
0
|
0.04
|
0.01
|
0.06
|
0.04
|
| EPS |
-0.04 |
0.02 |
0.14 |
0.11 |
0.38 |
0.0381 |
0.3 |
0.09 |
0.45 |
0.26 |
| EPS Diluted |
-0.0396 |
0.02 |
0.14 |
0.11 |
0.38 |
0.0381 |
0.29 |
0.09 |
0.45 |
0.26 |
| Weighted Average Shares Out |
$66.35 M
|
$67.37 M
|
$66.74 M
|
$65.47 M
|
$64.42 M
|
$63.44 M
|
$61.82 M
|
$60.64 M
|
$60.26 M
|
$59.92 M
|
| Weighted Average Shares Out Diluted |
$67.01 M
|
$67.79 M
|
$66.89 M
|
$65.61 M
|
$64.60 M
|
$63.44 M
|
$62.01 M
|
$61.23 M
|
$60.85 M
|
$60.13 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
